Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | METAP1 | P53582 | 3/20 | 0.46 |
| ▸ | CCR1 | P32246 | 3/20 | 0.46 |
| ▸ | CCR5 | P51681 | 3/20 | 0.46 |
| ▸ | CCR8 | P51685 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.46 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | METAP2 | P50579 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | TERT | O14746 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432185 | 1.00 | KDM4E (0.46) | KDM4ELMNAMETAP1CCR1CCR5 | |
| Magnesium SCHEMBL9418766 | 0.98 | KDM4E (0.45) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL9418754 | 0.98 | KDM4E (0.45) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL7571347 | 0.98 | KDM4E (0.45) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL599851 | 0.98 | KDM4E (0.45) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL601668 | 0.98 | KDM4E (0.45) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL29560659 | 0.98 | KDM4E (0.45) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL29560256 | 0.96 | METAP1 (0.44) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL31439451 | 0.93 | CCR1 (0.42) | KDM4ELMNAMETAP1CCR1CCR5 | |
| SCHEMBL25395411 | 0.92 | TOP1 (0.51) | SMN1; SMN2TERTHTTTOP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113555564-B | Preparation of supported non-noble metal electrocatalyst with MIL-88 as carrier and application of supported non-noble metal electrocatalyst in oxygen reduction reaction | 大连民族大学 | 2023-06-20 | — | — | CN | claimed |
| CN-110124714-B | Cu-N-C-based carbon nanosheet and preparation method and application thereof | 南京邮电大学 | 2022-08-30 | — | — | CN | claimed |
| US-20240325334-A1 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-10-03 | — | — | US | disclosed |
| WO-2023038386-A1 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | 서울대학교산학협력단 | 2023-03-16 | — | — | WO | disclosed |
| CN-110124714-B | Cu-N-C-based carbon nanosheet and preparation method and application thereof | 南京邮电大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-110124714-B | Cu-N-C-based carbon nanosheet and preparation method and application thereof | 南京邮电大学 | 2022-08-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240325334-A1 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | NOS1, NOS2, NOS3 | KDM4E 1345/4885LMNA 3619/4885METAP1 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.